Covered recipient · General Payments record
CHRISTINE DIENNA
Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease
General Payments · PY2018–2024
$8,892.11
- Reported across 160 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $646.15 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $322.64 | 11 |
| E.R. Squibb & Sons, L.L.C. | $309.65 | 6 |
| Lexicon Pharmaceuticals, Inc. | $13.86 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $18.94 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111563815 | CMS |
| Amgen Inc. | $124.79 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111563821 | CMS |
| Amgen Inc. | $14.87 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111563817 | CMS |
| Amgen Inc. | $31.70 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111563819 | CMS |
| Amgen Inc. | $20.93 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111563823 | CMS |
| Amgen Inc. | $7.13 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111563825 | CMS |
| Amgen Inc. | $16.21 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111563827 | CMS |
| Amgen Inc. | $26.36 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111563829 | CMS |
| Amgen Inc. | $13.00 | 11/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111563831 | CMS |
| Amgen Inc. | $17.49 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117541724 | CMS |
| Amgen Inc. | $31.22 | 12/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111563833 | CMS |
| E.R. Squibb & Sons, L.L.C. | $12.78 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101386470 | CMS |
| E.R. Squibb & Sons, L.L.C. | $5.74 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101386482 | CMS |
| E.R. Squibb & Sons, L.L.C. | $122.26 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101386552 | CMS |
| E.R. Squibb & Sons, L.L.C. | $122.26 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101386558 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.99 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101386526 | CMS |
| E.R. Squibb & Sons, L.L.C. | $28.62 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101386538 | CMS |
| Lexicon Pharmaceuticals, Inc. | $13.86 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1081709405 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.